Back
BioCryst Pharmaceuticals Stock Predictions
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
33
BCRX
BioCryst Pharmaceuticals
Last Price:
7.78
Seasonality Move:
8.68%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeBioCryst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 60.7% based on the past 30 years of stock performance.
- BioCryst Pharmaceuticals has risen higher in 14 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
-
Is BioCryst Pharmaceuticals Stock Undervalued?
The current BioCryst Pharmaceuticals [BCRX] share price is $7.78. The Score for BCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 60.7% based on the past 30 years of stock performance.
BioCryst Pharmaceuticals Stock Rating
Sell
33
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals overpriced?
- BioCryst Pharmaceuticals has risen higher in 14 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
BioCryst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
8.88
52-Week Low:
4.03
Prediction Charts
Market Cap:
1.61B
Price in USD:
7.78
Volume:
1.57M
Beta:
1.69
Technical Analysis
SMA50:
7.78
SMA100:
7.50
SMA200:
6.46
52-Wk Change:
42.23%
Stock Predictions
-
Is BioCryst Pharmaceuticals stock public?
Yes, BioCryst Pharmaceuticals is a publicly traded company. -
What is the BioCryst Pharmaceuticals stock quote today?
The BioCryst Pharmaceuticals stock price is 7.78 USD today. -
How to buy BioCryst Pharmaceuticals stock online?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-22 | 7.44 | 7.95 | 8.17 | 7.44 |
| Oct-23 | 7.92 | 8.06 | 8.12 | 7.88 |
| Oct-24 | 8.08 | 8.18 | 8.24 | 7.97 |
| Oct-25 | 8.19 | 7.95 | 8.23 | 7.95 |
| Oct-28 | 7.99 | 8.15 | 8.23 | 7.98 |
| Oct-29 | 8.11 | 8.11 | 8.17 | 8.00 |
| Oct-30 | 8.02 | 8.36 | 8.37 | 7.97 |
| Oct-31 | 8.31 | 8.02 | 8.38 | 7.99 |
| Nov-1 | 8.03 | 8.43 | 8.44 | 8.00 |
| Nov-4 | 7.77 | 7.35 | 7.96 | 6.85 |
| Nov-5 | 7.38 | 7.06 | 7.44 | 7.03 |
| Nov-6 | 7.19 | 7.73 | 7.74 | 7.10 |
| Nov-7 | 7.70 | 7.67 | 7.88 | 7.51 |
| Nov-8 | 7.55 | 7.78 | 7.84 | 7.52 |
BioCryst Pharmaceuticals Earnings
BioCryst Pharmaceuticals Earnings Report: Per Share BioCryst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals Forecast Revenue Growth
BioCryst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.35 per share.
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.